IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v466y2010i7307d10.1038_nature09171.html
   My bibliography  Save this article

Regulation of myeloid leukaemia by the cell-fate determinant Musashi

Author

Listed:
  • Takahiro Ito

    (Duke University Medical Center)

  • Hyog Young Kwon

    (Duke University Medical Center)

  • Bryan Zimdahl

    (Duke University Medical Center)

  • Kendra L. Congdon

    (Duke University Medical Center)

  • Jordan Blum

    (Duke University Medical Center)

  • William E. Lento

    (Duke University Medical Center)

  • Chen Zhao

    (Duke University Medical Center)

  • Anand Lagoo

    (Duke University Medical Center)

  • Gareth Gerrard

    (Imperial College London, Hammersmith Hospital)

  • Letizia Foroni

    (Imperial College London, Hammersmith Hospital)

  • John Goldman

    (Imperial College London, Hammersmith Hospital)

  • Harriet Goh

    (Seoul St Mary’s Hospital, The Catholic University of Korea)

  • Soo-Hyun Kim

    (Seoul St Mary’s Hospital, The Catholic University of Korea)

  • Dong-Wook Kim

    (Seoul St Mary’s Hospital, The Catholic University of Korea)

  • Charles Chuah

    (Singapore General Hospital, Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School)

  • Vivian G. Oehler

    (Fred Hutchinson Cancer Research Center)

  • Jerald P. Radich

    (Fred Hutchinson Cancer Research Center)

  • Craig T. Jordan

    (James P. Wilmot Cancer Center, University of Rochester School of Medicine)

  • Tannishtha Reya

    (Duke University Medical Center)

Abstract

Blocking leukaemia progress The molecular basis of the progression of chronic myeloid leukaemia from the chronic stage to the acute phase is poorly understood. Now, work in mouse models of chronic myeloid leukaemia shows that this progression is controlled by the cell fate regulator Musashi2, which in turn regulates Numb, Notch and p53 to block cellular differentiation. Musashi2 expression can be increased by aberrant transcription factors found in leukaemia and is observed during cancer progression in human patients with leukaemia, where it is associated with poorer prognosis. This raises the possibility that modulating Musashi–Numb associated signalling may serve as a new approach to therapies against this disease.

Suggested Citation

  • Takahiro Ito & Hyog Young Kwon & Bryan Zimdahl & Kendra L. Congdon & Jordan Blum & William E. Lento & Chen Zhao & Anand Lagoo & Gareth Gerrard & Letizia Foroni & John Goldman & Harriet Goh & Soo-Hyun , 2010. "Regulation of myeloid leukaemia by the cell-fate determinant Musashi," Nature, Nature, vol. 466(7307), pages 765-768, August.
    • Handle: RePEc:nat:nature:v:466:y:2010:i:7307:d:10.1038_nature09171
    DOI: 10.1038/nature09171
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature09171
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature09171?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Michelle M. Kameda-Smith & Helen Zhu & En-Ching Luo & Yujin Suk & Agata Xella & Brian Yee & Chirayu Chokshi & Sansi Xing & Frederick Tan & Raymond G. Fox & Ashley A. Adile & David Bakhshinyan & Kevin , 2022. "Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    2. Tatiana Erazo & Chiara M. Evans & Daniel Zakheim & Eren L. Chu & Alice Yunsi Refermat & Zahra Asgari & Xuejing Yang & Mariana Silva Ferreira & Sanjoy Mehta & Marco Vincenzo Russo & Andrea Knezevic & X, 2022. "TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    3. Wenxue Ma & Alejandro Gutierrez & Daniel J Goff & Ifat Geron & Anil Sadarangani & Christina A M Jamieson & Angela C Court & Alice Y Shih & Qingfei Jiang & Christina C Wu & Kang Li & Kristen M Smith & , 2012. "NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches," PLOS ONE, Public Library of Science, vol. 7(6), pages 1-14, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:466:y:2010:i:7307:d:10.1038_nature09171. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.